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Purpose: The purpose of this study was to assess functional status, well-being, and 
symptom relief of patients after infrainguinal revascularization for severe peripheral 
vascular disease. 
Methods: Two questionnaires were used to assess symptoms, functional status, and 
well-being before operation and 6 months after operation. Sociodemographics, omor- 
bidities, indications for surgery, graft location, and morbidity, mortality, patency, and 
limb salvage rates were obtained via vascular registry. 
Results: Of 318 patients who underwent revascularization ver a 1-year period, 276 
patients were asked to complete the questionnaires. Of the 156 patients who completed 
both questionnaires, mean age was 66 years, 67% were men, 84% had diabetes mellitus, 
and 83% had various heart-related conditions. Mean length of stay was 15.3 days. Distal 
graft sites were popliteal (29%), tibial/peroneal (40%), and pedal/plantar (31%). The 
operative morbidity rate was 21%, the cumulative primary graft patency rate was 93%, the 
cumulative secondary graft patency rate was 95%, and the limb salvage rate was 97% at 
6 months. At follow-up, improved functioning of instrumental ctivities of daily living, 
mental well-being, and vitality were reported. Symptoms of calf cramping and toe or foot 
pain when walking and at rest were also improved. Sores or ulcers improved, but leg 
swelling did not. The only independent predictor of improved fimction and well-being was 
the patients' perception of their status at baseline: those patients who functioned better 
before operation reported improved function and well-being at 6 months. Only 45% of 
patients reported feeling "back to normal" at 6 months. 
Conclusion: Reported health status at baseline was a predictor of improved function, 
mental well-being, and resolution of symptoms after infrainguinal revascularization. 
Expected return to "normal" may take longer than 6 months. (J VAsc SURG 1995;21: 
35.-45.) 
Helping patients with severe peripheral vascular 
occlusive disease (PVOD) attain the highest possible 
level of health, function, and well-being continues to 
be the goal of vascular surgeons. Health care reform 
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mandates that the treatment we provide be the most 
cost effective, while maintaining quality. ~ To assess 
this, there has been increasing emphasis on integrat- 
ing health-related quality of life outcomes from the 
patients' perspective with traditional measures of 
outcome. Although there are a variety of legitimate 
disease-specific and general health status outcome 
measures, their appropriateness for specific surgical 
specialties such as peripheral vascular surgery need to 
be further defined. 2-7 The vascular literature has 
focused on traditional outcomes documenting peri- 
operative morbidity, mortality, primary and second- 
ary patency, and limb salvage rates after infraingninal 
revascularization. Although most patients are grate- 
ful to have their leg saved, little attention has been 
given to how patients viewed their experience and its 
affect on their quality of life. The purpose of this 
study was to assess the ftmctional status, symptom 
35 
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Table I. Description of generic health status measures 
Scale Item(s) Response format 
General health perception In general, would you say your health Poor 
is... 
Instrumental ctivities of daily living* 
Social activities* 
Vitalityt 
Mental well-being~ 
Walking several blocks 
Walking one block or one flight of stairs 
Doing work around the house such as 
cleaning, light yard work, or home 
maintenance 
Doing errands uch as grocery shopping 
Driving a car or using public transpor- 
tation 
Doing vigorous activities uch as rtm- 
nin.g, lifting heavy objects, or partici- 
pating in strenuous sports 
Visiting with relatives or friends 
Participating in community activities uch 
as religious ervices, social activities, or 
volunteer work 
Taking care of other people such as fam- 
ily members 
Did you feel full of pep 
Did you have a lot of energy 
Did you feel worn out 
Did you feel tired 
Were you a very nervous person 
Did you feel calm and peaceful 
Did you feel downhearted and blue 
Were you a happy person 
Did you feel so down in the dumps that 
nothing could cheer you up 
Fair 
Good 
Very Good 
Excellent 
Usually did with no difficulty.. 
Usually did with some difficulty 
Usually did with much difficulty 
Usually did not do because of health 
Usually did not do for other reasons 
Same as instrumental ctivities of daily 
riving 
All of the time 
Most of the time 
A good bit of the time 
Some of the time 
A little of the time 
Most of the time 
Same as vitality 
*During the past month, how much difficulty did you have...? 
tDuring the past month, how much of the time...? 
relief, well-being, and overall general health percep- 
tion of patients undergoing infrainguinal revascular- 
ization. 
MATERIAL AND METHODS 
Patient sample. All patients undergoing infrain- 
guinal revascularization at the New England Dea- 
coness Hospital between December 1991 and De- 
cember 1992 were eligible for the study. Patients 
undergoing revascularization for aneurysmal disease 
were excluded. Interviews were conducted to deter- 
mine whether patients were medically able or willing 
to complete the questionnaires. The preoperative 
questionnaire was completed before vascular econ- 
struction and the follow-up questionnaire was mailed 
to patients 6 months after surgery. 
Data sources. Data sources consisted of medical 
records, office records, the vascular registry, and 
patient questionnaires. The vascular registry began in 
1990 to collect clinical data on all patients admitted 
to the vascular service who required any surgical 
procedure. The vascular registry included ata related 
to both inpatient hospitalization a d follow-up office 
visits. Inpatient data included emographics, comor- 
bid conditions, indications for surgery, diagnostic 
tests performed, surgical details (including subse- 
quent reoperations or other surgeries during the 
index hospitalization), complications, patency and 
mortality rates, and subsequent hospitalizations and 
surgeries. Follow-up data included mortality, graft 
patency, limb salvage, and wound healing rates for all 
surgeries. 
We classified patients into four groups represent- 
ing indications for surgery. The first group consisted 
of patients who had disabling claudication or rest 
pain only. The second group consisted of patients 
who had a nonhealing ulcer without infection, sep- 
sis, abscess, cellulitis, osteomyelitis, lymphangitis, or
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gangrene. The third indication group consisted of 
patients who had nonhealing ulcers complicated by 
infection, sepsis, abscess, cellulitis, osteomyelitis, 
lymphangitis, organgrene. The last group comprised 
patients who had thrombosed or failing grafts. 
Because only 21 patients (five completing both 
baseline and follow-up questionnaires) were assigned 
to this group, they were eliminated from the analyses 
reported here. 
Patients were also classified by the type of bypass 
depending on the distal anastomotic site. Group one 
consisted of bypasses to the above-knee or below- 
knee popliteal artery. Group two had bypasses to the 
tibial or peroneal artery, and group three had 
bypasses to the pedal or plantar arteries. 
We classified surgical complications into local 
(nonhealing ulcers or wounds, wound dehiscence, 
graft infection, wound infection, graft thrombosis 
and hemorrhage), systemic (pulmonary embolus, 
congestive heart failure, myocardial infarction, kid- 
ney failure, pneumonia, rrhythmia, sepsis, mukior- 
gan failure, clostridium difficile diarrhea, and urinary 
tract infections), and neurologic (thrombotic ere- 
bral vascular accident, hemorrhagic cerebral vascular 
accident, or transient ischemic attack). 
Health status questionnaire. The baseline and 
follow-up health status questionnaires were com- 
prised of identical condition-specific and generic 
health status measures. Condition-specific outcomes 
included questions about lower extremity peripheral 
vascular disease symptoms (cramping in calf, leg 
swelling, sores or ulcers that would not heal, limping, 
night time pain that prevents leep, foot or toe pain 
at rest, and foot or toe pain when walking). Patients 
were asked to rate how often they experienced ach 
of the symptoms, on a six-point scale ranging from all 
of the time to none of the time, over the month 
before completing the questionnaires. Patients also 
indicated whether they used walking devices, and 
they also described their ability to walk within their 
homes (move around on their own, need assistance 
[cane, crutches, walker, or other person], spend most 
of their time in a chair or wheelchair, and spend most 
of their time in bed). 
Generic measures of health status (Table I) 
consisted of a one-item measure of general health 
status (in general, would you say your health is 
excellent, very good, good, fair, or poor), as well as 
a six-item instrumental ctivities of daily living scale, 
a three-item social activity scale, and a five-item 
mental well-being scale, all from the Functional 
Status Questionnaire. 8 We also involved a four-item 
vitality scale from the SF-36 Health Survey. 9 The 
psychometric properties of these scales have been 
described elsewhere) ° Patients rated the amount of 
pain on a seven-point scale from no pain to severe 
pain, associated with eight activities (getting in and 
out of bed, rising from a sitting position, walking 
inside the house, walking outside of the house, 
climbing stairs, doing yard work/shopping, putting 
on stockings/pants, driving a car) they performed 
during the month before completion of each of the 
questionnaires. The scores for all eight activities were 
combined into a single pain score. All scale scores 
were linearly transformed to a range from 0 (least 
functional) to 100 (most functional) for ease of 
interpretation and presentation. As part of the 
follow-up questionnaire, patients were also asked to 
indicate whether they felt they were "back to normal" 
and whether the amount of physical activity they can 
perform is more, about the same, or less than their 
activity before surgery. 
Statistical analysis. We present statistics describ- 
ing the demographic and case mix characteristics of 
all eligible patients and of those who returned both 
health status questionnaires. We compared the char- 
acteristics of those patients who returned both ques- 
tionnaires with those who did not, with use of chi- 
squared testing for categorical variables and t testing 
for continuous variables. We compared the baseline 
and follow-up scores for each of the outcomes de- 
scribed above with use of paired t testing for continu- 
ous variables and chi-squared testing for categorical 
variables. We used multiple linear egression analysis 
to identify which demographic (age, sex) and clinical 
characteristics (indications for surgery, distal graft 
site, history of diabetes mellitus, myocardial infarc- 
tion, congestive heart failure, stroke, kidney disease, 
hypertension, or previous vascular surgery on the 
ipsilateral leg, major amputation of the contralateral 
leg, and baseline health status) were independent pre- 
dictors of health-related quality of life and symptom 
scores. 
The limb salvage rate was determined by the 
number of patients who had not undergone major 
amputation before discharge and at 6-month follow- 
up. Primary and secondary patency rates were deter- 
mined in accordance with Society for Vascu- 
lar Surgery/International Society for Cardiovascular 
Surgery criteria for graft patency. Both patency and 
limb salvage rates were determined by standard 
Kaplan-Meyer life-table methods. 
RESULTS 
Three hundred eighteen patients underwent in- 
fraingulnal revascularization for peripheral arterial 
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Table I I .  Demographic, linical, and process of  care characteristics of  patients 
All eligible (n = 318) Both surveys (n = 156) 
Characteristic No. ~ % No. % 
Demographic 
Age (yr.) 
Under 50 34 10.7% 
50-59 49 15.4% 
60-69 96 30.2% 
70-79 97 30.5% 
80 + 42 13.2% 
318 
Male sex 198/318 62.3% 
White race 288/318 90.9% 
Clinical 
Smoking status 
Never 69 21.7% 
Former 155 48.7% 
Current 67 21.1% 
Unknown 27 8.5% 
318 
Ambulatory 
Ambulatory 224 70.4% 
Ambulatory with assistance 64 20.1% 
Nonambulatory bedridden 9 2.8% 
Nonambulatory wheelchair 12 3.8% 
Unknown 9 2.8% 
318 
Any previous vascular surgery 196/318 61.6% 
Previous infraingulnal reconstruction 
Same limb 
Other limb 
Either limb 
Previous amputation 
Major, other side 
Minor, same side 
Minor, other side 
Prior CABG 
Comorbid iseases 
Diabetes 
Peripheral neuropathy 
Kidney disease 
Stroke 
14 9.0% 
27 17.3% 
52 33.3% 
46 29.5% 
17 10.9% 
156 
104/156 66.7% 
148/156 94.9% 
32 2O.5% 
86 55.1% 
26 16.7% 
12 7.7% 
156 
113 72.4% 
30 19.2% 
4 2.6% 
6 3.8% 
3 1.9% 
156 
91/156 58.3% 
58/318 18.2% 28/156 17.9% 
78/318 24.5% 39/156 25.0% 
113/318 35,5% 54/156 34.6% 
16/318 5.0% 8/156 5.1% 
51/318 16.0% 21/156 13.5% 
46/318 14.5% 21/156 13.5% 
46/318 14.5% 28/128 17.9% 
259/318 81.4% 131/156 84.0% 
196/281 69.8% 98/156 62.8% 
57/318 17.9% 22/156 14.1% 
48/318 15.1% 19/156 12.2% 
CABG, Coronary artery bypass grafting; 214/, myocardial infarction; CHF, congestive heart failure; LOS, length of stay; CVA, 
cerebrovascular accident; T/A, transient ischemic attack. 
~Includes nonhealing ulcer, nonhealing wound, graft occlusion, graft thrombosis, hemorrhage, wound dehiscence, graft infection, and 
wound infection. 
Hncludes pulmonary embolism, congestive heart failure, MI, kidneyfailure, pneumonia, arrhythmia, sepsis, multiorgan failure, 
Clostridrium difficile, and urinary tract infections. 
$Includes thrombotic CVA, hemorrhagic CVA, and TIA. 
occlusive disease. Baseline clinical data were obtained 
on all 318 patients. Forty-two patients were not 
asked to complete the questionnaire because they 
were too ill or had a language barrier. For example, 
several patients were admitted with severe sepsis 
requiring emergency operative debridement, and 
others had significant congestive heart failure on 
admission. Of  the 276 patients eligible for receiving 
the questionnaire, 26 patients refused. The baseline 
questionnaire was completed by 176 patients (71%). 
Both baseline and follow-up questionnaires were 
renamed by 156 patients (63%), who comprised our 
study group reported here. 
Patients who did not respond to either question- 
naire were more likely than respondents to have 
documented surgical complications and to be known 
current smokers. Respondents and nonrespondents 
did not differ from each other with respect to age, sex, 
race, indications for surgery, distal anastomotic site 
of the bypass, number of coexisting conditions, or 
ambulatory status. 
The demographic and clinical characteristics of all 
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Table  I I  (cont 'd) .  
Characteristic 
Al l  eligible (n = 318) Both surveys (n = 156) 
No. % No. % 
Heart disease 262/318 82.4% 130/156 83.3% 
MI 94/318 29.6% 47/156 30.1% 
Angina 36/318 11.4% 20/156 12.9% 
CHF 46/318 14.5% 24/156 15.4% 
Hypertension 182/318 57.2% 81/156 51.9% 
Indications for surgery 
Claudication and rest pain only 60 18.9% 35 22.4% 
Ulcer w/o infection, sepsis, abscess, cellulitis, 66 20.8% 37 23.7% 
osteomyelitis, lymphangitis or gangrene 
Infection, sepsis, abscess, cellulitis, osteomyelitis, 171 53.8% 79 50.6% 
lymphangitis, or gangrene 
Thrombosed or failing graft 21 6.6% 5 3.2% 
1-'gg 
Distal graft site groups 
Femoropopliteal 
Femorotibial or peroneal 
Femoropedal/plantar 
Other 
Mean LOS ( -+ SD) 
Death within 30 days 
Documented surgical complications 
Local* 
Systemjc~ 
Neurologic:~ 
Any of above classes 
84 26.4% 46 29.5% 
132 41.5% 62 39.7% 
100 31.4% 48 30.8% 
2 0.6% 0 0.0% 
318 156 
318 17.1 -+ 11.4 156 15.3 + 18.3 
1 0.3% 0 0.0% 
15 4.7% 8 7.0% 
30 9.4% 14 12.3% 
2 0.6% 2 1.8% 
47/318 14.8% 24/156 21.1% 
Tab le  I I I .  Patient health status reports at baseline and fol low-up 
No. Baseline mean Follow-Up mean Change (p value) 
General health rating* 134 45.0 43.8 N.S. 
Vitality* 124 53.0 61.1 < 0.001 
Instrumental ctivities of daily living* 106 53.6 65.6 < 0.001 
Mental well-being* 126 73.1 76.3 < 0.05 
Calf crampingt 124 68.9 84.0 < 0.001 
Leg swellingt 123 70.1 63.4 < 0.001 
Sores or ulcerst 122 49.5 83.8 < 0.001 
Toe or foot pain, restingj- 119 66.7 80.3 < 0.001 
Toe or foot pain, walkingt 119 62.7 76.8 < 0.001 
*Scores can range from 0 (least fimctional) to 100 (most functional). 
tScores can range from 0 (experienced symptom all of the time) to 100 (experienced symptom none of the time). 
eligible patients (n = 318) and those patients com- 
pleting both surveys (n = 156) are presented in 
Table II.  The distribution for these characteristics are 
similar for both groups. In both groups, most  
patients were younger than 70 years o f  age, male, 
white, fomaer smokers, and ambulatory on admis- 
sion. Most  patients had previous vascular surgery, 
diabetes mellitus, peripheral neuropathy, or heart 
disease and were admitted with infection (sepsis, 
abscess, cellulitis, osteomyelitis, lymphangitis) or 
gangrene complicating a nonheal ing ulcer. Fifteen 
percent o f  all patients had either a local, systemic, or 
neurologic complication after revascularization. 
The health status reports for those patients 
complet ing the baseline and fol low-up question- 
naires are presented in Table I I I .  The general health 
rating mean of  45 at baseline demonstrates that these 
patients have a low perception o f  their overall health, 
which did not improve at 6 months follow-up. All 
other measures o f  health status improved except for 
leg swelling, a known complication of  lower extrem- 
ity bypass, which was more of  a problem at 6 months 
than at baseline. Thirty-eight percent o f  patients 
responded that they were more active at fol low-up 
than before surgery, 32.5% reported their level o f  
physical activity was about the same, and 29.5% 
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Table IVA. Multiple regression models relating patient demographic and clinical characteristics to
health status outcomes 
Standardized beta weights 
General health Vitality IADL Mental well-being 
No. 128 121 103 122 
Age - 0.07 - 0.06 - 0.01 0.07 
Male sex ~ 0.1 0.01 0.12 - 0.1 
Diabetes ~ - 0.02 - 0.03 - 0.11 - 0.18]- 
Prior M I  ~ - 0.04 0.02 - 0.04 0.07 
CHF ~ 0.06 - 0.01 0.20 - 0.13 
Kidney disease ~ 0.06 - 0.03 - 0.15 0.04 
Stroke ~ -0 .03  0.18]- 0.03 0.11 
Hypertens ion ~ - 0.05 0.03 0.13 - 0.05 
Previous infrainguinal vascular surgery, same side ~ 0.00 - 0.08 0.03 0.06 
Major amputat ion,  other side ~ - 0.16 - 0.05 - 0.01 0.01 
Indications for surgery:~ 
Claudication or rest pain only ~ 0.11 0.07 0.23 -0 .02  
Ulcer only ~ 0.06 0.09 0.17 - 0.02 
Distal  graft site§ 
Femoral  or poplJteal ~ - 0.01 0.10 0.05 0.17 
Pedal or plantar ~ 0.10 0.11 0.09 0.23]- 
Baseline status 0.4711 0.5211 0.29¶ 0.55H 
R$ 0.29 0.31 0.26 0.45 
/ADL,  Instrumental  activities of  daily l iving; M/ ,  myocardial  infarction; CHF, congestive heart failure; R, mult iple correlation coeffi- 
cient. 
~Coded yes/no. 
?p < 0.05. 
$Compared wi th  infection, sepsis, abscess, cellulitis, osteomyelit is, lymphangit is,  or gangrene. 
§Compared wi th  tibial or peroneal. 
lip < 0.001. 
¶p < 0.01. 
reported being somewhat less or much less active. 
Less than half (47.4%) of the patients reported being 
"back to normal" at 6 months. The percent ofpatients 
requiring walking devices to get around increased 
from 63% at baseline to 74% at follow-up. 
Predictors of  health-related quality of  life 
outcomes. The results of our regression models are 
presented in Table IV. The models for predicting 
improvement in calf cramping and sores or ulcer 
healing did not predict significantly better than 
chance, and the results are not included in the table. 
One variable emerged as a consistent predictor of 
postdischarge functioning. For all measures, better 
functioning or symptoms status at baseline was 
associated with better fimctioning 6 months after 
surgery. 
Several other variables were significant predictors 
within specific regression models. Patients with a 
history of stroke reported more energy at follow-up 
than did other patients. Patients who underwent a
pedal or plantar bypass reported better mental 
well-being at follow-up than patients who underwent 
a tibial or peroneal bypass. Patients without diabetes 
mellitus reported better mental well-being than did 
patients with diabetes mellitus. Patients who under- 
went a bypass to the popliteal artery reported more 
foot or toe pain when resting than did patients who 
underwent a tibia] or peroneal bypass. 
For patients completing both questionnaires, the 
cumulative primary graft patency rate was 93%, the 
cumulative secondary graft patency rate was 95% 
(Table V, Fig. 1), and the limb salvage rate was 97% 
(Table V) at 6 months follow-up. No patients died 
between surgery and follow-up. 
DISCUSSION 
Patients with threatened limb loss can choose 
between potential limb salvage revascularization r
primary major amputation.11-14 Most patients choose 
the former because of the psychological nd emo- 
tional factors associated with major amputation. But 
the precise benefits associated with symptom relief, 
function, and well-being from the patient's perspec- 
tive associated with lower extremity revascularization 
are not known. For vascular surgery, effective, 
appropriate, and consistent clinical indicators of 
quality must be developed to help us examine our 
performance and effectiveness from the perspective 
of patient well-being. Procedural risks and benefits 
can be assessed by use of traditional outcomes of 
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Table IVB. Multiple regression models relating patient demographic and clinical characteristics to
health status outcomes 
Leg swelling Foot/toe pain, resting Foot/toe pain, walking 
No. 118 
Age 0.06 
Male sex* 0.16 
Diabetes* 0.04 
Prior MI* - 0.08 
CHF* - 0.02 
Kidney disease* 0.11 
Stroke* 0.06 
Hypertension* 0.02 
Previous infrainguinal vascular surgery, same side* - 0.09 
Major amputation, other side* 0.06 
Indications for surgeryt 
Claudication orrest pain only* -0.12 
Ulcer only* 0.00 
Distal graft sites 
Femoral or popliteal* 0.16 
Pedal or plantar* 0.07 
Baseline status 0.4311 
R~ 0.26 
116 117 
- 0.05 - 0.03 
- 0.03 - 0.07 
-0.19 -0.05 
- 0.04 - 0.07 
0.12 -0.05 
-0.11 -0.05 
0.15 0.11 
-0.16 -0.04 
0.03 0.05 
-0.02 0.13 
0.04 - 0.05 
0.01 - 0.02 
-0.23§ -0.17 
-0.12 -0.02 
0.28¶ 0.4211 
0.25 0.25 
MY, Myocardial infarction; CHF, congestive h art failure; R, ??? . 
*Coded yes/no. 
tCompared with infection, sepsis, abscess, cellulJtis, osteomyelitis, lymphangitis, or gangrene. 
:~Compared with tibial or peroneal. 
~p < 0.05. 
Ik~ < o.ool. 
¶p < 0.01. 
morbidity, mortality, graft patency, and limb salvage. 
For example, we have previously demonstrated a 
dramatic decrease in amputation rate, along with a 
reduction in cost and length of stay in recent 
years, is,16 Our present effort was to document the 
health-related quality of life beyond traditional mea- 
sures of our patients by asking them to report a 
variety of disease-specific and generic health status 
outcomes at baseline and at 6 months after infrain- 
guinal revascularization. 
This study helps us to answer the question "What 
should the patient with limb-threatening ischemia 
properly expect from infrainguinal revasculariza- 
tion?" On average, patients responding to the pre- 
operative baseline questionnaire and 6-month post- 
operative follow-up questionnaire noted significant 
improvement in all the function and symptom 
outcome measures we assessed except for leg swelling 
(Table III). For patients with sores or ulcers, there is 
significant healing. All measures of  pain improved. 
Finding effective measures of pain relief is a major 
objective of  the Joint Commission on Accreditation 
of Health Care Organizations for all diseases and 
their treatment. Schneider et al) 7 reported that 
bodily pain was greater in patients with severe PVOD 
after successful aorto bifemoral bypass when com- 
pared with patients in the medical outcomes tudy 
(MOS) group even after adjustment for comorbidi- 
ties. The preoperative baseline status of their patients, 
however, was not known and could have been much 
worse. We have shown that the potential patient 
benefit for significant pain relief after lower extremity 
revascularization can be shared with patients before 
operation and may improve their outlook. On 
average, patients reported improvement in vitality, 
mental well-being, and instrumental ctivities of daily 
living after operation. Albers et al)8 noted similar 
quality of life improvement in patients with chronic 
limb ischemia if major amputation was avoided. This 
quality of life improvement was sustained by a 
successful, functioning raft. 
It should be noted that not all study participants 
were able to or chose to complete both the baseline 
and follow-up questionnaires. Those patients who 
did not complete the questionnaires were more likely 
to be sicker than those who did. This suggests that the 
level of functioning reported may be the upper limit 
expected for the patients in our study who underwent 
lower extremity revascularization; if the number of 
respondents was increased by including those who 
were likely to be fimctioning poorly, the reported 
functional score would be lower. 
Did we find consistent predictors of  health- 
related quality of  life outcomes? In our model we 
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Fig. 1. Life-table primary and secondary patency r s for those patients completing both 
questionnaires. Numbers above each line indicate grafts at risk.
Table V. Primary and secondary graft patency and limb salvage in the study group 
Interval (too.) 
No. grafts withdrawn 
No. grafts No. failed patent due to Interval Cumulative Standard error
at risk grafts duration~death patency patency (%) (%) 
Primary patency 
0-1 156 
1-2 142 
2-3 135 
3-4 129 
4-5 123 
5-6 111 
Secondary patency 
0-1 156 
1-2 145 
2-3 139 
3-4 133 
4-5 127 
5-6 115 
Limb salvage 
0-1 156 
1-2 145 
2-3 139 
3-4 133 
4-5 128 
5-6 117 
3 11 0.98 100.00 0.00 
1 6 0.99 98.01 1.16 
2 4 0.98 97.30 1.38 
1 5 0.99 95.84 1.72 
3 9 0.97 95.08 1.90 
1 2 0.99 92.67 2.38 
0 11 1.00 100.00 0.00 
0 6 1.00 100.00 0.00 
2 4 0.99 100.00 0.00 
1 5 0.99 98.54 1.03 
3 9 0.98 97.79 1.29 
1 2 0.99 95.39 1.91 
0 11 1.00 100.00 0.00 
0 6 1.00 100.00 0.00 
2 4 0.99 100.00 0.00 
0 5 1.00 98.54 1.03 
2 9 0.98 98.54 1.05 
1 2 0.99 96.94 1.57 
controlled for clinical and sociodemographic c arac- 
teristics and found that the only independent predic- 
tor of function and well-being at 6 months was the 
patients' perception of their function and well-being 
at baseline. For these patients, health status at 
follow-up was independent of age, the indications for 
surgery, the distal anastomotic graft site, previous 
vascular surgery, prior contralateral major amputa- 
tion, or the presence ofcomorbidities such as diabetes 
mellitus or heart disease. The presence of an ulcer 
with an associated infection, sepsis, osteomyelitis, or
gangrene does not preclude improvement after re- 
vascularization despite the fact that these patients 
usually undergo multiple procedures: first to control 
infection, then infrainguinal revascularization, and 
later reconstructive foot surgery or local amputation 
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with a prolonged length of stay (20.6 days _ 12.8 
days in this study), and a gradual return to weight 
bearing with assistive devices. 
The general health rating baseline mean for 
patients with severe peripheral vascular disease in this 
study was low, 45, and did not change at 6 months 
after revascularization. This finding is similar to the 
general health perception reported by Schneider et 
al.17 and Albers et al.,lS who contend that the 
presence of severe peripheral vascular disease is an 
important independent predictor of decrements in 
functional health and well-being. We know that 
chronic comorbid conditions uch as diabetes melli- 
tus, heart disease, stroke, kidney disease, and arthritis 
adversely affect most aspects of functioning and 
well-being. 19,2° In this study the only independent 
predictor of postoperative general health status was 
the patients' general health status at baseline. 
Independent of the other clinical and sociodemo- 
graphic characteristics, patients with diabetes melli- 
tus fared worse at 6 months with regard to mental 
well-being. Guadagnoli et al.21 noted that patients 
with diabetes mellitus function more poorly on 
instnamental activities of daily living and social 
activities than did patients without diabetes mellitus 
6 months after coronary artery bypass grafting. This 
may be not be surprising considering the complica- 
tions associated with diabetes mellitus itself. 4 Of  
significance also is the symptom of leg swelling, a 
known complication of  infrainguinal revasculariza- 
r.ion, which patients report is worse 6 months after 
operation and deserves attention to seek remedies for 
improvement. 
Only 47.4% of respondents reported feeling 
"back to normal" at 6 months. It may be that 6 
months is not an adequate time for recovery. Many of  
these patients still require walking devices (63.2% 
baseline/74% follow-up), which is not surprising 
considering that half of  the bypasses were done for 
nonhealing ulcers complicated by infection, gan- 
grene, or osteomyelitis and often required multiple 
reconstructive foot surgery procedures. 
For most of the condition-specific and generic 
health outcome measures, we evaluated better pa- 
tient-reported health status before the lower extrem- 
ity revascularization predicted better postoperative 
fimction and well-being. This finding supports fur- 
ther investigation toidentify factors associated with a 
poor overall general health rating reported by pa- 
tients with severe PVOD and what their expectations 
are. Earlier intervention directed toward improving 
patient function and well-being before operation may 
additionally maximize the patient benefit of  ou]; re- 
vascularization procedures. We encourage national 
and regional vascular societies to explore quality man- 
agement echnologies and health status outcome 
measures to better define those that are most appro- 
priate for vascular surgery so that we may best serve 
our patients and society. 
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DISCUSSION 
Dr. Martha McDaniel (White River Junction, Vt.). 
We hold a variety of responsibilities as vascular surgeons. 
The first is to understand how to produce atechnically 
optimal result when we intervene for vascular disease. 
The second is to understand the natural history of the 
disease we treat, so we can best advise patients concerning 
their options; what's likely to happen to them if they 
continue as they are; and what is likely to happen to them 
if they undertake a specific treatment, usually on our advice. 
Our job is to be patient advocates, to put ourselves in their 
places, and, knowing what we know as physicians, to help 
them decide what to do next. 
The lives of patients have many more dimensions than 
graft patency. To be sure, technically optimal results 
underlie overall good results, but as we have seen, even a 
95% graft patency rate does not produce uniformly 
unassisted walking ability or improved personal estimate of 
overall health. 
This study joins a growing number of studies of the 
overall fimction of patients after infrainguinal revascular- 
ization for lower extremity arterial occlusive disease. It joins 
recent studies, as you have pointed out, notably the work 
of Mbers et al.,18 Mangione, Donaldson, and their col- 
leagues (Presented at the Nineteenth Annual Meeting of 
the New England Society for Vascular Surgery, Dixville 
Notch, N.H.; Sept. 24-25, 1992) at the Brigham and 
Women's Hospital in Boston, and Schneider et al. 17 Your 
work demonstrates that infrainguinal revascularization 
does, on average, reduce pain by about half, and does 
promote healing of tissue. There are many residual issues, 
though, as we seek to help patients understand what life 
may be like after a planned intervention. 
First, would you consider analyzing your data further 
or sharing with us a further analysis that you've already 
done, so that we might more easily be able to answer the 
type of questions a patient might ask? For example, your 
multiple linear regression analysis tells us how much of 
the variation in outcome score is predicted by the fact, 
for example, that claudication was the indication for 
operation- all other factors being the same - but it doesn't 
tell us how much improvement that patient with claudica- 
tion might expect. It would be usefifl to have the prediction 
rule in hand, even though the clinical factors we all would 
study do not fully predict he outcomes we look at. 
My second question has to do with the proper 
interpretation fyour patients' reports of symptoms. How 
reliable are their answers from day to day, even in the 
absence of a health status change? How does the preop- 
erative to postoperative difference in reported symptoms 
compare with baseline variability in the absence of a 
reconstructive procedure? 
Last, I find it most disturbing, as you have found, that 
your study, along with the previously reported ones, are 
uniform in their findings that the overall health perception 
of patients with lower extremity occlusive disease is not 
much improved even by hemodynamically successful 
bypass. Patients who have undergone successful bypass 
believe themselves to be as ill as or more ill than patients 
with chronic conditions uch as congestive heart failure, at 
6 months and longer, in Schneider's experience, lz since 
their revascularization. Can you explain this, and do you 
have any suggestions for how we might improve their 
condition? 
Dr. Gary W. Gibbons. I think what people have to 
appreciate is that with these questionnaires, this is the 
current state of the art, and I think an important message 
here is to try to devise a health status questionnaire that 
specifically covers a lot of the condition-specific symptoms 
and indications for surgery, such as clandication, that we as 
vascular surgeons can use in our day-to-day practice to 
predict better the outcome of various treatment modalities. 
I think you're working on specific vascular surgery 
outcome status measures that, it is hoped, will help us in 
this endeavor. 
Specifically all patient-reported symptoms (except leg 
swelling) and ftmction significantly improved in this study, 
and we can share this with patients. The better they felt and 
functioned at baseline, the better they were at 6 months. 
I must say, when we did this with my vascular surgery 
colleagues, I think we were all a little bit perplexed by the 
low level of general health perception that the patients had. 
Even after we read other centers' experiences, and, certainly 
as the Moss outcome study has shown, we found that 
patients with comorbid conditions have decrements in 
functional health and well-being. I think what we need to 
do is further study these patients and to find out why their 
perception of their health is so low so that we can come up 
with interventions to try to improve their baseline status. I 
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think, as we've shown here, improving their baseline status 
will better improve their status at 6 months after lower 
extremity revascularization. 
Dr. Jack L. Cronenwett (Lebanon, N.H.). Perhaps 
we shouldn't be too discouraged about the failure to 
improve the overall well-being in these patients, because 
most of them are undergoing limb salvage operations such 
that we are, in reality, trying to preserve their quality of life 
and not necessarily improve it. 
My question relates to the fact that you were able to 
administer the questionnaire to about half of your pa- 
tients, and one worries about he bias introduced by those 
patients who agree to respond. You told us what the 
overall graft patency rate is, which is the normal way that 
we evaluate these patients. Was the patency rate in the 
group that responded ifferent from the patients who 
didn't respond to your questionnaire? Do we have to 
worry about any differences between responders and 
nonresponders? 
Dr. Gibbons. The only difference that we found 
between responders and nonresponders was that nonre- 
sponders were more likely to have had a major complica- 
tion, were current or former smokers, and, although this 
was not significant, they had a longer length of stay. 
Dr. Robert W. Barnes (Little Rock, Ark.). My 
question relates to the evaluation of patients who don't 
come to surgical intervention. Do you have experience with 
these questionnaires in your practice of patients who are 
treated without operation? 
And second, what would be your thoughts with regard 
to whether the outcomes might differ if such question- 
naires were given by us as subspecialists versus primary care 
physicians? 
Dr. Gibbons. We all need to get on the same playing 
field with our medical colleagues and come up with a 
specific health status outcome questionnaire that we can all 
use, starting with when someone first sees the patient, such 
as internists or vascular medicine specialists, and carries 
right through for those patients who undergo operative 
intervention. We do have data on 100 patients with 
claudication that we have not yet analyzed, and it is hoped 
that this will be a project for us to complete in the future. 
Dr. George Andros (Burbank, Calif.). Those of us 
who do a lot of paramaneolar bypasses are always asked by 
the patients, "Will I be able to put a shoe back on?" These 
grafts go very distally, and, if they have a lace-up shoe that's 
tight, they're concerned. Maybe this is one reason that they 
don't resume the activity that you might anticipate. What 
do you tell these people? 
The second question relates to the work that we did on 
plantar bypasses a few years back, and, in our series of 
patients, everyone who left the hospital with a patent graft 
resumed walking, at least walking as well as they were 
before, and 50% of the people went back to work. Do you 
have any other outcomes you could tell us about, such as 
return to work, because often these are younger diabetic 
patients who, in fact, do work. 
And finally, because ducation does change perception, 
do you have any information on education of these patients 
and how they perceive all of the factors that you've 
analyzed? 
Dr. Gibbons. I think the important thing people have 
to remember about shoeing is that half of our patients 
underwent operation for an ulcer complicated by signifi- 
cant infection. Many of these patients undergo an initial 
surgical debridement, followed by revascularization, fol- 
lowed by reconstructive foot surgery, which, it is hoped, 
avoids even local amputation. These patients don't walk on 
that foot for about 4 weeks. We use a lot of healing sandals 
and then progress the weight bearing in shoes with 
orthotics. Most patients end up wearing orthotics but are 
able to wear regular shoes. It's very rare for these patients 
to have to go into an extra-depth shoe. But I think the 
important thing that we share with them is that they will 
be able to wear shoes. They just need to rotate their shoes 
during the day. 
As far as returning to work, we don't have that data yet. 
As far as education of patients, I think this work again 
i s very young. As Dr. McDaniel alluded to, there aren't a 
great many studies about this in the vascular literature. I 
think we need to maximize ducational efforts at helping 
people understand an illness, such as peripheral vasaalar 
disease, as well as any associated comorbid conditions, and 
how it affects their function and well-being. This will help 
us as physicians and certainly help our residents provide 
better value to their care. 
